COVID-19 Archives

December 12, 2022

CLL Society’s COVID-19 Update for the Week of December 12th, 2022

CLL Society’s COVID-19 Update for the Week of December 12th, 2022: The update for this week will be abbreviated due to CLL Society staff attending ASH. Numbers have sharply increased this past week and the dominant variants that are not sensitive to Evusheld continue to dominant the variant landscape.

December 5, 2022

CLL Society’s COVID-19 Update for the Week of December 5th, 2022

As expected, after much of the US gathered indoors for the Thanksgiving holiday weekend, COVID-19 numbers are once again headed in the wrong direction after an autumn lull.

December 1, 2022

FDA Pauses Authorization for Last Remaining COVID-19 Monoclonal Antibody Treatment

Bebtelovimab joins the long list of “here and gone” anti- SARS-CoV-2 monoclonal antibodies that are no longer reliably effective in treating COVID-19 due to mutations in the dominant variants of concern. For the past monoclonals such as REGEN-COV or sortovimab, Omicron rendered them ineffective.

November 28, 2022

CLL Society’s COVID-19 Update for the Week of November 28th, 2022

CLL Society’s COVID-19 Update for the Week of November 28th, 2022: Here is your weekly summary of what has been happening this past week in the United States. Keep in mind, data is always going to be delayed/underreported when there is a holiday weekend due to government offices being

November 21, 2022

CLL Society’s COVID-19 Update for the Week of November 21st, 2022

CLL Society’s COVID-19 Update for the Week of November 21st, 2022: Here is your weekly summary of what has been happening this past week in the United States. The variant picture continues to shift rapidly. Read more on this below.

November 18, 2022

ASH 2021: Antibody and T-Cell Responses to COVID-19 mRNA Vaccines in Patients with B-Cell Lymphomas and Chronic Lymphocytic Leukemia (CLL)

Compared to the earlier study, this one used a larger and broader cohort of patients. They included patients with diagnoses of CLL, and related B-cell lymphomas, namely marginal zone lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Waldenstrom’s macroglobulinemia.

November 18, 2022

ASH 2021: Humoral (Antibody) and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL

In the past three years since SARS-CoV-2 has been active, patients with compromised or suppressed immune systems have worried, wondered, and waited for an answer to the one big question -will treatment or immunizations work for me?

November 14, 2022

CLL Society’s COVID-19 Update for the Week of November 14th, 2022

CLL Society’s COVID-19 Update for the Week of November 14th, 2022: Here is your weekly summary of what has been happening this past week in the United States. The variant picture continues to shift rapidly. Read more on this below.

November 14, 2022

Many Patients with Weak Immune Systems Don’t Realize Their COVID-19 Medicine Isn’t as Effective as It Used to Be

CNN interviewed CLL Society’s Dr. Brian Koffman and Robyn Brumble, RN, among others, to gain perspective on the significance of the diminishing susceptibility of the emerging SARS-CoV-2 Variants of Concern (VOC) to Evusheld, the only Pre-Exposure Prophylaxis (PrEP) for the immunocompromised; including all those with chronic lymphocytic leukemia/small lymphocytic

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

COVID-19

CLL Society’s COVID-19 Update for the Week of December 12th, 2022

CLL Society’s COVID-19 Update for the Week of December 5th, 2022

FDA Pauses Authorization for Last Remaining COVID-19 Monoclonal Antibody Treatment

CLL Society’s COVID-19 Update for the Week of November 28th, 2022

CLL Society’s COVID-19 Update for the Week of November 21st, 2022

ASH 2021: Antibody and T-Cell Responses to COVID-19 mRNA Vaccines in Patients with B-Cell Lymphomas and Chronic Lymphocytic Leukemia (CLL)

ASH 2021: Humoral (Antibody) and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL

CLL Society’s COVID-19 Update for the Week of November 14th, 2022

Many Patients with Weak Immune Systems Don’t Realize Their COVID-19 Medicine Isn’t as Effective as It Used to Be

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT CLL SOCIETY

CONTACT